InDex Pharmaceuticals in brief
InDex is a pharmaceutical development company focusing on immunological diseases where there is a high unmet medical need for new treatment options. The company’s lead asset is the drug candidate cobitolimod, which is being evaluated in the phase III study CONCLUDE as a novel treatment of moderate to severe ulcerative colitis – a debilitating, chronic inflammation of the large intestine. InDex has also developed a platform of patent protected discovery stage substances, so called DNA based ImmunoModulatory Sequences (DIMS), with the potential to be used in the treatment of various immunological diseases.
InDex is based in Stockholm, Sweden. The company’s shares (ticker INDEX) are traded on Nasdaq First North Growth Market Stockholm.
Company Details
- Employees
- 10
- Founded
- -
- Address
- Berzelius Väg 13, Solna,stockholm County 171 65,sweden
- Phone
- 46 8 50 88 47 30
- in****@****rma.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- indexpharma.com
- HQ
- Solna, Stockholm County
Index Pharmaceuticals Ab Questions
Index Pharmaceuticals Ab's helpline number is 46 8 50 88 47 30
Index Pharmaceuticals Ab's website is indexpharma.com
Index Pharmaceuticals Ab's LinkedIn profile is https://se.linkedin.com/company/index-pharmaceuticals-ab
Index Pharmaceuticals Ab has
10 employees.
View email and phone details for 10
employees at Index Pharmaceuticals Ab.
Index Pharmaceuticals Ab's industry is
Pharmaceutical Manufacturing
Index Pharmaceuticals Ab's top competitors are
Immedica Pharma Ab,
Xbrane Biopharma Ab,
Gesynta Pharma Ab,
Pelago Bioscience Ab,
Vicore Pharma Ab,
Egetis Therapeutics Ab,
Alzecure Pharma,
Moberg Pharma Ab,
Flerie,
Isofol Medical Ab (Publ).
Index Pharmaceuticals Ab's support email address is info@indexpharma.com
Index Pharmaceuticals Ab's categories are Pharmaceutical Manufacturing
Index Pharmaceuticals Ab's founding year is 2000
